ConductScience.org, home

Paper475375

Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans.

Billiau A and 4 others. Antimicrob Agents Chemother, 1979. Cited by 79 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans. Papers, record 475375. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/475375

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
79
iCite
Relative citation ratio, by iCite
2.87
iCite
Revised in PubMed
2021-05-26
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Billiau AA
2De Somers PP
3Edy VGV G
4De Clercq EE
5Heremans HH

Source PubMed

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FibroblastsMajor topic
InterferonsMajor topic
Adolescent
Adult
Animals
Antigens, Viral
Child
Child, Preschool
Female
Fever
Humans
Hypersensitivity, Delayed
Injections, Intramuscular
Injections, Intravenous
Lymphopenia
Male
Middle Aged
Pyrogens
Rabbits
Skin Tests

Source PubMed

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1631,632Treatment of HBsAg-positive chronic active hepatitis with human fibroblast interferon.Gut1978https://conductscience.org/library/papers/631632PubMed
270,611Interferon skin reactivity and pyrexial reactions.Lancet1977https://conductscience.org/library/papers/70611PubMed
375,485Non-appearance of injected fibroblast interferon in circulation.Lancet1978https://conductscience.org/library/papers/75485PubMed
473,970Fibroblast interferon in HBsAg-positive chronic active hepatitis.Lancet1977https://conductscience.org/library/papers/73970PubMed
569,141Interferon-induced skin reactivity in man.Lancet1977https://conductscience.org/library/papers/69141PubMed
6100,331Double-blind study of interferon administration in renal transplant recipients.Eur J Clin Invest1978https://conductscience.org/library/papers/100331PubMed
7347,294Human leukocyte interferon for the treatment of herpes zoster in patients with cancer.N Engl J Med1978https://conductscience.org/library/papers/347294PubMed
8475,374Human fibroblast interferon for clinical trials: production, partial purification, and characterization.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/475374PubMed
9893,388Purification of human fibroblast interferon by zinc chelate affinity chromatography.J Biol Chem1977https://conductscience.org/library/papers/893388PubMed
101,036,458Purification of interferon by adsorption chromatography on controlled pore glass.J Gen Virol1976https://conductscience.org/library/papers/1036458PubMed
11965,787Morphology of delayed-type hypersensitivity reactions in man.J Invest Dermatol1976https://conductscience.org/library/papers/965787PubMed
124,947,653In vitro approaches to the mechanism of cell-mediated immune reactions.Adv Immunol1971https://conductscience.org/library/papers/4947653PubMed
134,601,181Administration of human leukocyte interferon in herpes zoster. I. Safety, circulating, antiviral activity, and host responses to infection.J Infect Dis1974https://conductscience.org/library/papers/4601181PubMed
144,355,215Clinical and laboratory investigations on man: systemic administration of potent interferon to man.J Natl Cancer Inst1973https://conductscience.org/library/papers/4355215PubMed
154,129,735Letter: Interferon in acute leukaemia in children.Lancet1974https://conductscience.org/library/papers/4129735PubMed
1660,513Administration of human fibroblast interferon in chronic hepatitis-B infection.Lancet1976https://conductscience.org/library/papers/60513PubMed
174,719,686Biological effects of bacterial endotoxins in man.J Infect Dis1973https://conductscience.org/library/papers/4719686PubMed
18779,593Biology of endotoxin.Annu Rev Med1976https://conductscience.org/library/papers/779593PubMed
19950,957Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis.N Engl J Med1976https://conductscience.org/library/papers/950957PubMed
20932,502Comparison of rates of clearance of human fibroblast and leukocyte interferon from the circulatory system of rabbits.J Infect Dis1976https://conductscience.org/library/papers/932502PubMed

See all 22 references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.

PMIDTitleJournalYearIn PapersSource
24,272,847Potentiation of enteral absorption of human interferon alpha and selective transfer into lymphatics in rats.Pharm Res1985https://conductscience.org/library/papers/24272847PubMed
8,984,676Mechanisms of action of interferon-beta in multiple sclerosis.Springer Semin Immunopathol1996https://conductscience.org/library/papers/8984676PubMed
7,354,125Pharmacokinetic properties of human fibroblast and leukocyte interferon in rabbits.J Clin Microbiol1980https://conductscience.org/library/papers/7354125PubMed
6,400,034The clinical application of fibroblast interferon--an overview.Med Oncol Tumor Pharmacother1984https://conductscience.org/library/papers/6400034PubMed
6,379,511Clinical effect of interferon in malignant brain tumours.Neurosurg Rev1984https://conductscience.org/library/papers/6379511PubMed
6,177,285Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6177285PubMed
6,173,188Interferons and interferon inducers: development of clinical usefulness and therapeutic promise.Drugs1982https://conductscience.org/library/papers/6173188PubMed
6,171,428Comparison of human fibroblast and leukocyte interferon in the treatment of severe laryngeal papillomatosis in children.Eur J Pediatr1981https://conductscience.org/library/papers/6171428PubMed
6,166,278Tissue distribution of human interferons after exogenous administration in rabbits, monkeys, and mice.Arch Virol1981https://conductscience.org/library/papers/6166278PubMed
6,165,341Differences between human alpha (leukocyte) and beta (fibroblast) interferons.Arch Virol1981https://conductscience.org/library/papers/6165341PubMed
6,163,417Interferon therapy: pharmacokinetic and pharmacological aspects.Arch Virol1981https://conductscience.org/library/papers/6163417PubMed
6,160,588Spontaneous production of human interferon.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6160588PubMed
6,160,109Interferon in experimental viral infections in mice: tissue interferon levels resulting from the virus infection and from exogenous interferon therapy.Infect Immun1980https://conductscience.org/library/papers/6160109PubMed
6,159,043Interferon: therapeutic fact or fiction for the '80s?Br Med J1980https://conductscience.org/library/papers/6159043PubMed
6,088,712Chemosensitivity of malignant human brain tumors. Preliminary results.J Neurooncol1983https://conductscience.org/library/papers/6088712PubMed
4,031,971Interferon-beta in patients with low-grade astrocytomas--a phase I study.J Neurooncol1985https://conductscience.org/library/papers/4031971PubMed
3,493,097Pyrogenic and haematological effects of the interferon-inducing 22K factor (interleukin 1 beta) from human leukocytes.Clin Exp Immunol1986https://conductscience.org/library/papers/3493097PubMed
2,425,443Interferons: current status and future directions of this prototypic biological.Springer Semin Immunopathol1986https://conductscience.org/library/papers/2425443PubMed
2,068,966Distribution of mouse interferon-beta in normal and brain tumour-bearing mice.Acta Neurochir (Wien)1991https://conductscience.org/library/papers/2068966PubMed
1,702,693Clinical pharmacokinetics of interferons.Clin Pharmacokinet1990https://conductscience.org/library/papers/1702693PubMed

See all 21 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/475375

GET https://conductscience.org/api/papers/v1/475375/references?page=2